MEDICENNA THERAPEUTICS CORP (MDNA.CA) Stock Analyst Ratings
TSX:MDNA - Toronto Stock Exchange - CA58490H1073 - Common Stock - Currency: CAD
ChartMill assigns a Buy % Consensus number of 82% to MDNA.CA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 5.74. This target is 399.37% above the current price.
MDNA.CA was analyzed by 10 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about MDNA.CA.
In the previous month the buy percentage consensus was at a similar level.
MDNA.CA was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-11-29 | Guggenheim Securities | Initiate | Buy |
| 2022-11-29 | STA Research | Downgrade | Speculative Buy |
| 2022-09-29 | STA Research | Maintains | Speculative Buy |
| 2022-09-29 | HC Wainwright | Downgrade | Buy |
| 2022-08-16 | Bloom Burton | Downgrade | Buy |
| 2022-08-16 | Jones Trading | Downgrade | |
| 2022-08-10 | Oppenheimer Holdings | Initiate | Buy |
| 2022-08-10 | STA Research | Reiterate | Speculative Buy |
| 2022-07-28 | Bloom Burton | Maintains | Buy |
| 2022-06-23 | STA Research | Maintains | Speculative Buy |
| 2022-06-23 | HC Wainwright | Reiterate | Buy |
| 2022-04-13 | Brookline Capital | Upgrade | Buy |
| 2022-03-15 | Maxium Group | Initiate | Buy |
| 2021-09-22 | Bloom Burton | Initiate | Buy |